About this episode

This episode discusses the implications of GLP-1 on the food industry and consumer behavior.

This episode brings together four conversations on the topic of GLP-1 the science, the market data, the human impact, and the long-term strategic picture. We hear from scientists, market strategists, clinicians and food innovators on what GLP-1 actually means for the food industry, and what it means for the people eating differently because of it. Some market data suggests households on GLP-1 medications are spending 6% less on food overall. The consumer segment using these drugs in the UK is already roughly the same size as the vegan and vegetarian market. How the food industry responds to this disruptive influence remains an open question, although serious moves are already being made.

People in this episode

Host: Food Matters Live

Topics covered

• GLP-1
• food industry
• market data
• human impact
• strategic picture

Keywords

• GLP-1
• food industry
• market data
• consumer behavior
• medications

Mentioned in this episode

Organizations: GLP-1, UK

More episodes of Food Matters Live Podcast

• 612: Sustainable food production - how the industry is making progress · June 1, 2026 · 25 min
• 610: Permissible indulgence - making healthy food feel like a treat · May 18, 2026 · 38 min
• 609: Reformulation doesn't have to mean compromise - but it does mean asking the right questions · May 11, 2026 · 32 min

Explore listener stats, chart rankings, contacts and more on the Food Matters Live Podcast podcast page.